These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12705750)

  • 1. Lichen planus and leukocytoclastic vasculitis induced by interferon alpha-2b in a subject with HCV-related chronic active hepatitis.
    Pinto JM; Marques MS; Correia TE
    J Eur Acad Dermatol Venereol; 2003 Mar; 17(2):193-5. PubMed ID: 12705750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective evaluation of dermatological side-effects during alpha-interferon therapy for chronic viral hepatitis.
    Dalekos GN; Christodoulou D; Kistis KG; Zervou EK; Hatzis J; Tsianos EV
    Eur J Gastroenterol Hepatol; 1998 Nov; 10(11):933-9. PubMed ID: 9872615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocytoclastic vasculitis during pegylated interferon and ribavirin treatment of hepatitis C virus infection.
    Adişen E; Dizbay M; Hizel K; Ilter N
    Indian J Dermatol Venereol Leprol; 2008; 74(1):60-2. PubMed ID: 18187830
    [No Abstract]   [Full Text] [Related]  

  • 4. Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area.
    Maticic M; Poljak M; Lunder T; Rener-Sitar K; Stojanovic L
    J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):779-88. PubMed ID: 18452521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pegylated interferon associated lichen planus at the injection site.
    Ergül B; Koçak E; Akbal E; Köklü S; Astarci HM
    Acta Gastroenterol Belg; 2011 Dec; 74(4):591-2. PubMed ID: 22319976
    [No Abstract]   [Full Text] [Related]  

  • 6. Exacerbation of oral lichen planus lesions during treatment of chronic hepatitis C with pegylated interferon and ribavirin.
    Grossmann Sde M; Teixeira R; de Aguiar MC; do Carmo MA
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):702-6. PubMed ID: 18679075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association of chronic hepatitis C and lichen planus--in two patients].
    Podányi B; Lengyel G; Kiss A; Szakonyi J; Schaff Z; Fehér J
    Orv Hetil; 2006 Mar; 147(12):547-50. PubMed ID: 16696378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multiple extrahepatic manifestations in a patient with chronic hepatitis C treated with interferon-alfa].
    Napoli N; Tortorella C; Deramo MT; Antonaci A; Parisi CV; Antonaci S
    Recenti Prog Med; 2004 Nov; 95(11):525-8. PubMed ID: 15598090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exacerbation of oral erosive lichen planus by combination of interferon and ribavirin therapy for chronic hepatitis C.
    Nagao Y; Kawaguchi T; Ide T; Kumashiro R; Sata M
    Int J Mol Med; 2005 Feb; 15(2):237-41. PubMed ID: 15647837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C.
    Hsieh MC; Yu ML; Chuang WL; Shin SJ; Dai CY; Chen SC; Lin ZY; Hsieh MY; Liu JF; Wang LY; Chang WY
    Eur J Endocrinol; 2000 May; 142(5):431-7. PubMed ID: 10802518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lichen planus associated with hepatitis C virus: no viral transcripts are found in the lichen planus, and effective therapy for hepatitis C virus does not clear lichen planus.
    Harden D; Skelton H; Smith KJ
    J Am Acad Dermatol; 2003 Nov; 49(5):847-52. PubMed ID: 14576663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lichen planus and chronic hepatitis C: exacerbation of the lichen under interferon-alpha-2a therapy.
    Areias J; Velho GC; Cerqueira R; Barbêdo C; Amaral B; Sanches M; Massa A; Saraiva AM
    Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):825-8. PubMed ID: 8864684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lichen planus induced by interferon-alpha-2a therapy for chronic active hepatitis C.
    Barreca T; Corsini G; Franceschini R; Gambini C; Garibaldi A; Rolandi E
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):367-8. PubMed ID: 7600144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.
    Campistol JM; Esforzado N; Martínez J; Roselló L; Veciana L; Modol J; Casellas J; Pons M; de Las Cuevas X; Piera J; Oliva JA; Costa J; Barrera JM; Bruguera M
    Nephrol Dial Transplant; 1999 Nov; 14(11):2704-9. PubMed ID: 10534516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
    Farrell GC; Bacon BR; Goldin RD
    Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy.
    Myers RP; Benhamou Y; Bochet M; Thibault V; Mehri D; Poynard T
    AIDS; 2004 Jan; 18(1):75-9. PubMed ID: 15090832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: results from Kyushu University Liver Disease Study.
    Ogawa E; Furusyo N; Kajiwara E; Takahashi K; Nomura H; Tanabe Y; Satoh T; Maruyama T; Nakamuta M; Kotoh K; Azuma K; Dohmen K; Shimoda S; Hayashi J;
    J Gastroenterol Hepatol; 2012 Jul; 27(7):1233-40. PubMed ID: 22098185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of side effects during therapy with different types of alpha interferon: a randomised controlled trial comparing recombinant alpha 2b versus leukocyte interferon in the therapy of naive patients with chronic hepatitis C.
    Ascione A; De Luca M; Di Costanzo GG; Picciotto FP; Lanza AG; Canestrini C; Morisco F; Tuccillo C; Caporaso N
    Curr Pharm Des; 2002; 8(11):977-80. PubMed ID: 11945144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral lichen planus induced by interferon-alpha-N1 in a patient with hepatitis C.
    Varela P; Areias J; Mota F; Canelhas A; Sanches M
    Int J Dermatol; 2000 Mar; 39(3):239-40. PubMed ID: 10836860
    [No Abstract]   [Full Text] [Related]  

  • 20. Sustained exacerbation of cryoglobulinaemia-related vasculitis following treatment of hepatitis C with peginterferon alfa.
    Batisse D; Karmochkine M; Jacquot C; Kazatchkine MD; Weiss L
    Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):701-3. PubMed ID: 15201585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.